Though 83O' of 168 cancer patients admitted for "terminal care" died within 12 weeks of admission predictions of the probable length of survival showed little relation to the actual length of survival. A total of 83% of all "errors" were in an "optimistic" direction, the patient being expected to survive longer than he actually did.
Introduction
The prediction of the probable length of survival of dying patients is one of the least welcome tasks undertaken by medical and nursing personnel. Our ability to make such predictions correctly is likely to be important to patients and their families. The decision when to admit a patient for "terminal care," what prognosis to give to the relatives, how much time is available for imparting important but emotionally disturbing information, when relatives should be permitted to stay with the patient overnight, when the "death watch" should begin, and how much time is available to allow antidepressant drugs or other medicaments, whose therapeutic effects may not become apparent at once, to have their full effect are only a few of the reasons why it is important for us to make predictions which are accurate or, if this is not possible, to have some idea of the reliability of those predictions we do make.
Glaser and Strauss' claimed that "Death expectations are a key determinant in how everyone acts during the dying process.... Miscalculations in forecasting or perceiving trajectories can play havoc with the organization of work-as when one association between predicted and actual survival in most cases the level of correlation was low (r = 0 24-0 28). A week after admission an interesting paradox was apparent. Predictions made at that time by hospice physicians were even more likely to be errors than they were on the day of admission, but the correlation between prediction and survival had risen to r = 0-42. This is explained by an increase in the consistency of the errors. Dividing all predictions by two would have reduced the proportion of errors by half (to 30%).
Ward sisters and senior nurses also showed an increase in correlation between prediction of survival and actual survival when the predictions were made a week after admission (r = 0 37), but unlike those made by the physicians these were associated with a reduction in the number of errors made (42%).
The proportion of "optimistic" errors are shown in Table 1I . Here too there is no significant difference between groups. Predictions were consistently optimistic (830// of all errors were in the optimistic direction).
Conclusions
These findings throw serious doubt on the accuracy with which doctors and nurses are able to predict when a patient in the later 31 stages of cancer is likely to die. Not that such predictions are meaningless; the fact that 830/ of these patients died within 12 weeks of admission is itself a confirmation that the patients were rightly regarded as being in a "terminal" state.
These patients cannot, of course, be regarded as completely typical of cancer patients because of the means of selection of cases for admission, but neither are they highly atypical. We have no reason to believe that cancer patients dying in southeast London are different from those dying elsewhere. Most cancer patients die in hospital (610 according to figures for England and Wales in 19682), and although patients in the older age bracket are under-represented the sample did include many elderly patients.
One possible explanation for the consistent optimism which must be considered is the possibility that the treatment which is provided for patients at St. Christopher's Hospice actually shortens their lives. If this were the case we would expect that the physicians and nurses at the hospice, whom one would expect to adopt the institutional "norm" of survival, would be more realistic in their expectations than those who work in other settings. But this is not the case, nor was there any evidence that patients given diamorphine (the principal drug given for pain in that institution) died sooner than those who did not receive this drug. It seems, then, that this explanation must be set aside.
Because uncertainty is hard to bear relatives and even patients sometimes press their doctors to give them a precise estimate of prognosis. We often hear the phrase "The doctor gave him x weeks to live," usually followed by a "but" and a disclosure of The manifestations of a phaeochromocytoma depend on the relative amounts of adrenaline and noradrenaline it produces. Adrenaline increases the pulse rate, the systolic blood pressure, and the cardiac output, while noradrenaline increases peripheral vascular tone and blood pressure. These different actions correspond with those mediated by beta-sympathetic and alphasympathetic transmission. Thus the effects of excessive circulating catecholamines in a patient with phaeochromocytoma canbe blocked by using alpha-sympathetic and beta-sympatheticbu-king drugs.
Alpha receptors, which are responsible for vasoconstriction, hypertension, sweating, and contraction of the erector pilae muscles, may be blocked by such drugs as phenoxybenzamine or phentolamine. Beta receptors are blocked by drugs like propranolol. Alpha-sympathetic and beta-sympathetic-blocking drugs play an important part both in the diagnosis of phaeochromocytoma and particularly in the management of the patient during surgical treatment.
Another aspect of the differing effects of catecholamines is in their administration for therapeutic purposes. The administration of adrenaline makes good sense in patients with bronchial asthma or heart block, but is clearly contraindicated in hypo-
